World News

Patient Guide on Immunotherapy Side Effects and Their Management Now Available...

Ogkologos - 26 Νοεμβρίου, 2025

Patient Guide in Testicular Cancer Now Available Also in Italian

Ogkologos - 25 Νοεμβρίου, 2025

Adding 177Lu-PNT2002 to SBRT Significantly Improves PFS in Patients with Oligorecurrent...

Ogkologos - 24 Νοεμβρίου, 2025

A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target...

Ogkologos - 21 Νοεμβρίου, 2025

FDA Approves Ziftomenib for Relapsed or Refractory Acute Myeloid Leukaemia with...

Ogkologos - 20 Νοεμβρίου, 2025

NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared...

Ogkologos - 18 Νοεμβρίου, 2025

ESMO Publishes First-Ever Guidance on Validation Requirements for AI-Based Biomarkers in...

Ogkologos - 18 Νοεμβρίου, 2025

ESMO AI & Digital Oncology Congress 2025 Closed in Berlin under...

Ogkologos - 17 Νοεμβρίου, 2025

No EFS Benefit From Adding Atezolizumab To 1-Year BCG Therapy In...

Ogkologos - 17 Νοεμβρίου, 2025

Strengthening EU Support for Rare Cancers under the 2028–2034 Multiannual Financial...

Ogkologos - 17 Νοεμβρίου, 2025

1...323334...432 Σελίδα 33 από 432

MOST POPULAR

Triple Negative Breast Cancer May Not Be Categorized As ‘Breast’ Cancer...

4 Φεβρουαρίου, 2020

How serendipity sent this oncologist in search of a cure for...

12 Αυγούστου, 2022

For Women with Breast Cancer, Regular Exercise May Improve Survival

15 Μαΐου, 2020

Navigating the Challenges of Gynecologic Cancer Survivorship: An Expert Perspective

10 Μαΐου, 2022

Φόρτωση περισσοτέρων

Patient Guide on Immunotherapy Side Effects and Their Management Now Available...

Patient Guide in Testicular Cancer Now Available Also in Italian

Adding 177Lu-PNT2002 to SBRT Significantly Improves PFS in Patients with Oligorecurrent...

A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target...

FDA Approves Ziftomenib for Relapsed or Refractory Acute Myeloid Leukaemia with...

NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared...

ESMO Publishes First-Ever Guidance on Validation Requirements for AI-Based Biomarkers in...

ESMO AI & Digital Oncology Congress 2025 Closed in Berlin under...

No EFS Benefit From Adding Atezolizumab To 1-Year BCG Therapy In...

Strengthening EU Support for Rare Cancers under the 2028–2034 Multiannual Financial...

MOST POPULAR

Triple Negative Breast Cancer May Not Be Categorized As ‘Breast’ Cancer...

How serendipity sent this oncologist in search of a cure for...

For Women with Breast Cancer, Regular Exercise May Improve Survival

Navigating the Challenges of Gynecologic Cancer Survivorship: An Expert Perspective

HOT NEWS

The Cancer Moonshot: Moving from Planning to Research

Get to Know CaringBridge

Born Blind With 50% Chance Of Survival, 20-Year-Old Musician Defied All...

A Meaningful Benefit of the Quadruplet-Based Isatuximab Plus VRd Regimen in...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ